PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region - United States, 2006-2015.

Abstract Opioid overdose deaths quadrupled from 8,050 in 1999 to 33,091 in 2015 and accounted for 63% of drug overdose deaths in the United States in 2015. During 2010-2015, heroin overdose deaths quadrupled from 3,036 to 12,989 (1). Sharp increases in the supply of heroin and illicitly manufactured fentanyl (IMF) are likely contributing to increased deaths (2-6). CDC examined trends in unintentional and undetermined deaths involving heroin or synthetic opioids excluding methadone (i.e., synthetic opioids)* by the four U.S. Census regions during 2006-2015. Drug exhibits (i.e., drug products) obtained by law enforcement and reported to the Drug Enforcement Administration's (DEA's) National Forensic Laboratory Information System (NFLIS) that tested positive for heroin or fentanyl (i.e., drug reports) also were examined. All U.S. Census regions experienced substantial increases in deaths involving heroin from 2006 to 2015. Since 2010, the South and West experienced increases in heroin drug reports, whereas the Northeast and Midwest experienced steady increases during 2006-2015.(†) In the Northeast, Midwest, and South, deaths involving synthetic opioids and fentanyl drug reports increased considerably after 2013. These broad changes in the U.S. illicit drug market highlight the urgent need to track illicit drugs and enhance public health interventions targeting persons using or at high risk for using heroin or IMF.
PMID
Related Publications

Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016.

Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Increases in Fentanyl-Related Overdose Deaths - Florida and Ohio, 2013-2015.

Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.

Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014.

Authors

Mayor MeshTerms
Keywords
Journal Title mmwr. morbidity and mortality weekly report
Publication Year Start




PMID- 28859052
OWN - NLM
STAT- MEDLINE
DA  - 20170831
DCOM- 20170905
LR  - 20170906
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 66
IP  - 34
DP  - 2017 Sep 01
TI  - Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and 
      Law Enforcement Drug Product Reports, by Census Region - United States,
      2006-2015.
PG  - 897-903
LID - 10.15585/mmwr.mm6634a2 [doi]
AB  - Opioid overdose deaths quadrupled from 8,050 in 1999 to 33,091 in 2015 and
      accounted for 63% of drug overdose deaths in the United States in 2015. During
      2010-2015, heroin overdose deaths quadrupled from 3,036 to 12,989 (1). Sharp
      increases in the supply of heroin and illicitly manufactured fentanyl (IMF) are
      likely contributing to increased deaths (2-6). CDC examined trends in
      unintentional and undetermined deaths involving heroin or synthetic opioids
      excluding methadone (i.e., synthetic opioids)* by the four U.S. Census regions
      during 2006-2015. Drug exhibits (i.e., drug products) obtained by law enforcement
      and reported to the Drug Enforcement Administration's (DEA's) National Forensic
      Laboratory Information System (NFLIS) that tested positive for heroin or fentanyl
      (i.e., drug reports) also were examined. All U.S. Census regions experienced
      substantial increases in deaths involving heroin from 2006 to 2015. Since 2010,
      the South and West experienced increases in heroin drug reports, whereas the
      Northeast and Midwest experienced steady increases during 2006-2015.dagger In the
      Northeast, Midwest, and South, deaths involving synthetic opioids and fentanyl
      drug reports increased considerably after 2013. These broad changes in the U.S.
      illicit drug market highlight the urgent need to track illicit drugs and enhance 
      public health interventions targeting persons using or at high risk for using
      heroin or IMF.
FAU - O'Donnell, Julie K
AU  - O'Donnell JK
AD  - Division of Unintentional Injury Prevention, National Center for Injury
      Prevention and Control, CDC.
FAU - Gladden, R Matthew
AU  - Gladden RM
AD  - Division of Unintentional Injury Prevention, National Center for Injury
      Prevention and Control, CDC.
FAU - Seth, Puja
AU  - Seth P
AD  - Division of Unintentional Injury Prevention, National Center for Injury
      Prevention and Control, CDC.
LA  - eng
PT  - Journal Article
DEP - 20170901
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
RN  - 0 (Analgesics, Opioid)
RN  - 0 (Designer Drugs)
RN  - 0 (Street Drugs)
RN  - 70D95007SX (Heroin)
RN  - UF599785JZ (Fentanyl)
SB  - IM
MH  - Analgesics, Opioid/*poisoning
MH  - Censuses
MH  - Designer Drugs/*poisoning
MH  - Drug Overdose/*mortality
MH  - Fentanyl/*poisoning
MH  - Heroin/*poisoning
MH  - Humans
MH  - Law Enforcement
MH  - Mortality/trends
MH  - Street Drugs/*legislation & jurisprudence/*poisoning
MH  - United States/epidemiology
EDAT- 2017/09/01 06:00
MHDA- 2017/09/07 06:00
CRDT- 2017/09/01 06:00
AID - 10.15585/mmwr.mm6634a2 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2017 Sep 1;66(34):897-903. doi:
      10.15585/mmwr.mm6634a2.